Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men

Diabetes and Metabolism

Volumn 36, Issue 3, 2010, Pages 192-197

  Ko, G T C ^a   So, W Y ^a   Tong, P ^a   Ma, R C ^a   Kong, A P ^a   Ozaki, R ^a   Yang, X ^a   Ho, C S ^a   Lam, C W ^a   Chan, J C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adiponectin; Diabetes; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHINESE; DIABETES MELLITUS; GLUCOSE INTOLERANCE; HUMAN; HYPOADIPONECTINEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTOR VARIABLE; PROTEIN DEFICIENCY; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; ANALYSIS OF VARIANCE; BLOOD; CHI SQUARE DISTRIBUTION; CHINA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CHINA; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 77953477611     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.11.007     Document Type: Article

References (27)

1. Lihn A.S., Pedersen S.B., and Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6 (2005) 13-21
2. Brakenhielm E., Veitonmaki N., Cao R., Kihara S., Matsuzawa Y., Zhivotovsky B., et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 101 (2004) 2476-2481
3. Winer J.C., Zern T.L., Taksali S.E., Dziura J., Cali A.M., Wollschlager M., et al. Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome. J Clin Endocrinol Metab 91 (2006) 4415-4423
4. Yamauchi T., Kamon J., Waki H., Imai Y., Shimozawa N., Hioki K., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
5. Kantartzis K., Rittig K., Balletshofer B., Machann J., Schick F., Porubska K., et al. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem 52 (2006) 1934-1942
6. Ronti T., Lupattelli G., and Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64 (2006) 355-365
7. Hashimoto N., Kanda J., Nakamura T., Horie A., Kurosawa H., Hashimoto T., et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 55 (2006) 1653-1657
8. Higashiura K., Ura N., Ohata J., Togashi N., Takagi S., Saitoh S., et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf) 61 (2004) 753-759
9. Ko G.T., and Tang J.S. Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for "central pre-obesity". Obesity (Silver Spring) 15 (2007) 2832-2839
10. Chow W.S., Cheung B.M., Tso A.W., Xu A., Wat N.M., Fong C.H., et al. Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49 (2007) 1455-1461
11. Mather K.J., Funahashi T., Matsuzawa Y., Edelstein S., Bray G.A., Kahn S.E., et al. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57 (2008) 980-986
12. Matsumoto M., Ishikawa S., and Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 39 (2008) 323-328
13. Shaibi G.Q., Cruz M.L., Weigensberg M.J., Toledo-Corral C.M., Lane C.J., Kelly L.A., et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab 92 (2007) 1809-1813
14. Ko G.T., Chan J.C., Tong S.D., Chan A.W., Wong P.T., Hui S.S., et al. Associations between dietary habits and risk factors for cardiovascular diseases in a Hong Kong Chinese working population--the "Better Health for Better Hong Kong" (BHBHK) health promotion campaign. Asia Pac J Clin Nutr 16 (2007) 757-765
15. Tong P.C., Ho C.S., Yeung V.T., Ng M.C., So W.Y., Ozaki R., et al. Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. J Clin Endocrinol Metab 90 (2005) 6418-6423
16. WHO. World Health Organization (WHO): appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
17. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome--a new world-wide definition A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
18. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
19. Simel D.L., Samsa G.P., and Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44 (1991) 763-770
20. Im J.A., Kim S.H., Lee J.W., Shim J.Y., Lee H.R., and Lee D.C. Association between hypoadiponectinemia and cardiovascular risk factors in non obese healthy adults. Metabolism 55 (2006) 1546-1550
21. James P.T., Leach R., Kalamara E., and Shayeghi M. The worldwide obesity epidemic. Obes Res 9 Suppl. 4 (2001) 228S-233S
22. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006) 1681-1688
23. Choi K.M., Lee J., Lee K.W., Seo J.A., Oh J.H., Kim S.G., et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 61 (2004) 75-80
24. Snehalatha C., Mukesh B., Simon M., Viswanathan V., Haffner S.M., and Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26 (2003) 3226-3229
25. Despres J.P., and Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444 (2006) 881-887
26. Kubota N., Terauchi Y., Yamauchi T., Kubota T., Moroi M., Matsui J., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 (2002) 25863-25866
27. Gu W., Li X., Liu C., Yang J., Ye L., Tang J., et al. Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine 30 (2006) 217-221